Lemborexant price forecast and market dynamics in 2026

As Lemborexant is officially launched in China, its market price and future trends have become the focus of many insomnia patients. At present, the original drug of Leborexen has been approved in China, with the trade name of Daveco, and the common specifications are 5 mg × 14 tablets × 2 plates. Due to the short time it has been on the market, its specific retail price is still uncertain in different regions, but what is clear is that it has not been included in the national medical insurance directory at this stage, which means that patients need to pay for it out of pocket.

Japan is one of the first regions where LebraRasen was launched and its application is relatively mature. The common specifications of the Japanese version of the original medicine are 5 mg × 100 tablets, and the price per box is about one thousand yuan equivalent to RMB. Compared with some traditional sleep aids, this price is at a moderate level, reflecting its technical premium as a new orexin antagonist. At present, generic drugs of Lebrasin have not been officially launched in the mainstream market, which also allows the original drug to maintain its price dominance in the short term.

In terms of domestic market forecasts, the price trend of Lebraxen depends largely on patient acceptance and clinical use scope. If it shows good tolerability and stable sleep-aiding effect in the real world, it does not rule out the possibility of being re-evaluated in medical insurance negotiations in the future. However, in the short term, as a non-medical insurance sleep aid, its price will still be an important factor affecting the size of the user population.

Analysed from the perspective of market dynamics, Lebrasen represents the development direction of "a new generation of sleep aids". Its non-sedative and non-benzodiazepine positioning is gradually attracting the attention of doctors and patients. With the popularization of the concept of sleep medicine, the market space of Lebrasin may come more from the demand for substitution of traditional sleeping pills rather than pure price competition. Generally speaking, its price and market performance will gradually become clear under the combined effect of efficacy awareness, policy environment and patient demand.

Reference materials:https://medlineplus.gov/druginfo/meds/a620039.html